Corpus Intelligence IC Memo — MERIT HEALTH WESLEY 2026-04-26 09:04 UTC
IC Memo — MERIT HEALTH WESLEY
Investment Committee Memorandum | MS | 121 beds | Grade C | EBITDA uplift $10.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MERIT HEALTH WESLEY

CCN 250094 | LAMAR, MS | 121 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MERIT HEALTH WESLEY is a 121-bed suburban community hospital in LAMAR, MS with $140.9M in net patient revenue and a 1.3% operating margin. The hospital serves a payer mix of 31.0% Medicare, 17.3% Medicaid, and 51.7% commercial.

Thesis: Undervalued. Our ML models identify $10.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.3% to 8.7% (+736bps).

Net Revenue HCRIS$140.9M
Current EBITDA COMPUTED$1.8M
Operating Margin COMPUTED1.3%
Occupancy HCRIS82.3%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS9.5%
Distress Probability ML42.0%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
26
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of 1.3% places it above the state median. Among 26 size-comparable peers (60-242 beds), the median margin is -4.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (60-242), prioritizing same-state peers. 26 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MERIT HEALTH WESLEY (Target)MS121$140.9M1.3%
BAPTIST MEM HOSPITAL NORTH MISMS195$229.4M0.7%
BAPTIST MEM HOSPITAL GOLDEN TRMS154$221.1M6.9%
MAGNOLIA HOSPITALMS158$161.6M-4.7%
CENTRAL MISSISSIPPI MEDICAL CEMS226$142.2M-12.4%
RIVER OAKS HOSPITALMS158$124.1M7.0%
SOUTHWEST MS REGIONAL MED CENTMS97$123.1M-16.0%
RUSH FOUNDATION HOSPITALMS191$122.0M-19.1%
BAPTIST MEM HOSPITAL UNION COUMS83$117.9M3.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.0M+210bp18mo
Cost to Collect4.5%2.5%$2.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.7M+122bp9mo
Clean Claim Rate88.0%96.0%$90K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.0M
Cost to Collect
$2.8M
Denial Rate Reduction
$2.8M
A/R Days Reduction
$1.7M
Clean Claim Rate
$90K
Total EBITDA Uplift$10.4M
Current EBITDA$1.8M
+ RCM Uplift+$10.4M
Pro Forma EBITDA$12.2M
Current Margin1.3%
Pro Forma Margin8.7%
WC Released (1x)$5.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.8M$115.8M41.05x110.2%
Base (11x exit)10.0x11.0x$2.8M$128.3M45.48x114.6%
Bull Case9.0x11.0x$2.5M$163.5M64.37x130.0%
Bull (12x exit)9.0x12.0x$2.5M$179.1M70.51x134.2%
Bear Case11.0x10.0x$3.1M$63.1M20.31x82.6%
Bear (11x exit)11.0x11.0x$3.1M$70.4M22.67x86.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 26 hospitals with 60-242 beds
  • Same-state prioritization (n=27)
  • Comp margins: P25=-16.0% / P50=-4.4% / P75=3.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.